Viyash Scientific: FY26 मध्ये नफ्यात वाढ! Appco Pharma च्या जोरावर कंपनीने साधला इतिहास
NiveshIQ
NSE: VIYASH · Healthcare
Viyash Scientific Ltd.
₹256.75▲ ₹3.30 (+1.30%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on VIYASH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Viyash Scientific Ltd.
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally, providing finished dosage formulations in therapeutic areas such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. The company also offers analytical services and VET formulation services. Its recent partnership with Boehringer Ingelheim aims to expand its companion animal portfolio in India. Viyash Scientific Limited has achieved a record-breaking EBITDA and has reached a 52-week high of Rs 277.05. The company's revenue stood at ₹3420 Cr, with a net income of ₹177 Cr. As a subsidiary of CA Harbor Investments, Viyash Scientific Limited has a strong backing and is expected to continue its growth trajectory. W
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,369 Cr -3.70% | ₹1,935 Cr +41.30% | ₹3,420 Cr |
| EBITDA Margin | 4.46% | 11.73% | 20.35% |
| Net Profit | -75.40% | ₹67.00 Cr -323.30% | ₹268.86 Cr |
| EPS | ₹-1.45 | ₹2.51 | ₹4.09 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Viyash Scientific FY26 Profit Rises as Appco Pharma Leads Growth
Broker’s call: Viyash Scientific (Buy)
🔒
+ 3 more stories about Viyash Scientific Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹920 Cr, PAT ₹66 Cr, EPS ₹1.20, EBITDA margin 21.8%. Growth context: revenue QoQ +7.2%, PAT QoQ +72.7%. Street verdict: strong beat, revenue surprise +1.0%, PAT surprise +21.4%.
Recent corporate activity highlights strategic partnerships and joint ventures as the primary near-term growth lever, wi...
FY26 (last completed FY): revenue ₹3, 420 Cr, PAT ₹269 Cr, EBITDA margin 20.4%, EPS ₹4.09. Street consensus for FY27e: r...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for VIYASH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track VIYASH alongside your other holdings
Unlock full VIYASH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Viyash Scientific Ltd.?
NiveshIQ detects active intelligence signals for Viyash Scientific Ltd. (VIYASH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Viyash Scientific Ltd.?
Viyash Scientific Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,120,008.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.